Team: Kintsugi Mindfull Wellness, Inc. | Origin: California | Participation: NSF I-Corps Participant 2020
Kintsugi is developing voice biomarker software to measure, predict, and scale access to mental healthcare with more effective screening and triage. With just 20 seconds of free form speech, its product, KiVA (Kintsugi Voice Biomarker API), can detect if an individual may require further screening for depression and anxiety.
KiVA integrates seamlessly across complex clinical workflows and provides real-time scoring on voice data in call centers, telehealth platforms, and remote patient monitoring apps. KiVA is language agnostic and trained on the world’s largest annotated voice dataset with users from over 250 international cities. By using KiVA, practitioners can enrich patient interactions with deeper screening and evaluation, ultimately improving patient outcomes. Between 2020 and 2022, Kintsugi raised over $ 26.5 million.
“The I-Corps experience helped us define our target market and create our commercialization plan. The customer discovery interviews were especially valuable because they forced us to take a step back from our day-to-day product development and focus on the challenges and needs of our end customers. After interviewing accomplished experts, consultants, and key opinion leaders in our space, we systematically reviewed, evaluated, and ranked our opportunities by size and barriers to entry. This systematic approach helped us make data driven decisions on our go-to-market strategy.” Grace Chang, Founder and CEO, Kintsugi Mindful Wellness, Inc.